clinical trial · NCT07290257
Long-Term Low-Intervention SafEty and Clinical Outcomes Clinical Study of LivmArli® in Patients With Alagille Syndrome in the European Union (LEAP-EU)
Alagille SyndromeLivmarli Oral Product
brief summary
The key objectives of this low-intervention clinical study are to evaluate tolerability, long-term safety and long-term efficacy for patients with Alagille syndrome (ALGS) who are prescribed Livmarli.
started
Sep 25, 2025
primary completion
Sep 22, 2030
completion
Dec 22, 2030
last updated
Dec 18, 2025
detailed description
This is a multicenter, open-label, low-intervention clinical study in participants diagnosed with Alagille syndrome (ALGS) who are treated with Livmarli for cholestatic pruritus.
Participants will be treated according to standard of care for the duration of the study and Schedule of Assessments.
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol